Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nicholas Simon Insider Profile
4 Followers
Nicholas Simon, Director at Sientra, holds 101.57K shares in Sientra (Ticker: SIENQ), holds 2.57M shares in Gritstone Oncology (Ticker: GRTS), holds 73.59K shares in Achillion Pharmaceuticals (Ticker: ~ACHN).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+93.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Nicholas Simon holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nicholas Simon
Nicholas Simon's Trading History
Sientra
Jun 15, 2021
Director
Uninformative Buy
―
$5.08K
Gritstone Oncology
Oct 02, 2018
Director, Ten Percent Owner
Uninformative Buy
―
$2.52M
Achillion Pharmaceuticals
Jun 06, 2012
―
Uninformative Buy
―
$497.49K
List of latest transactions for each holding click on a transaction to see Nicholas Simon's performance on stock
You May Also Like
Nicholas Simon insider profile FAQ
What is the percentage of profitable transactions made by Nicholas Simon?
The percentage of profitable transactions made by Nicholas Simon is 50%.
What is the average return per transaction made by Nicholas Simon?
The average return per transaction made by Nicholas Simon is 93.20%.
What stocks does Nicholas Simon hold?
Nicholas Simon holds: SIENQ, GRTS, ~ACHN stocks.
What was Nicholas Simon’s latest transaction?
Nicholas Simon latest transaction was an Uninformative Buy of ―.
What was Nicholas Simon's most profitable transaction?
Nicholas Simon’s most profitable transaction was an Informative Buy of SIENQ stock on October 28, 2014. The return on the trade was 217.30%.
What is Nicholas Simon's role in Sientra?
Nicholas Simon's role in Sientra is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.